Rapid nano drug preparation system

NegotiableUpdate on 05/06

Model

Nature of the Manufacturer: Producers

Product Category

Place of Origin

Online Consult

Overview

INano L/L+$r $n $r $n Prescription Optimization Magnifying process screening $r $n $r $n Features: $r $n1, 0.4-20ml preparation volume (0.4-60ml preparation volume) $r $n2, rapid prescription screening (<1min) $r $n3, cartridge sterile, enzyme free, and pyrogen free $r $n4, temperature control $r $n5, compatible with various brands of syringes $r $n6, cartridge unlimited usage times $r $n7, 2-in-1, supporting both prescription and magnifying process screening $r $n8, flow rate controllable ≥ 120ml/min, multiple fluid models available, suitable for multiple carrier types $r $n8

Product Details

Rapid nano drug preparation system

The INano L/L+LNP encapsulation system is not only an early LNP prescription screening system, but also an amplification process screening system, which breaks through the gap from laboratory preparation of mRNA/LNP to large-scale production preparation, greatly accelerating the commercialization process of your laboratory research results.

Performance of INano L&L+

Dual function of prescription screening and amplification process screening
Uniform particle size, high encapsulation efficiency, and high repeatability
Preparation volume:0.4-20ml（60ml*）
Flow rate range:1-150ml/min（300ml/min*）
Heating range: room temperature -80 ° C
Diversified mixed structure options:

Microfluidic mixing, T-mixer, as well as various customized or third-party hybrid chips
Multi level user permission management, audit tracking, compliantFDA 21CFR part 11
Seamless amplification, consistent results

*INano L+applicable

Characteristics of INano L&L+

Higher encapsulation efficiency and more uniform particle size

Compared to traditional manual mixing or other competitors, the carefully designed and optimized microfluidic mixing model by Meina,Higher encapsulation efficiency (up to 90% or more), smaller and more uniform particle size (PDI<0.15).

Higher and more stable in vitro and in vivo transfection efficiency

The INano L/L+microfluidic device has been tested in both domestic and international markets. With the witness of over 500 users, it can achieve higher and more stable in vitro and in vivo transfection efficiency for your lipid nanoparticle samples.

Simplified amplification conversion, high amplification consistency

On the INano L/L+microfluidic device, pilot production chips can be used for amplification process screening. Only ml level mRNA/LNP samples are needed for optimizing the production amplification process of lipid nanoparticles, greatly reducing the difficulty and material cost of mRNA/LNP amplification development.

No limits, give you freedom

Whether it's the hybrid structure of microfluidic chips, the injector brand used in microfluidic mixing, or the chip brand, you can choose the number of times to use it freely without any restrictions, and you are free!

<<< END >>>